Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: results of a randomized study

K Sliwa, A Woodiwiss, VN Kone, G Candy… - Circulation, 2004 - Am Heart Assoc
Background—Inflammatory immune activation commonly occurs in heart failure and may
perpetuate this syndrome. We sought to determine whether the immunomodulating agent …

Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated congestive heart failure secondary to idiopathic dilated …

K Sliwa, A Woodiwiss, G Candy, D Badenhorst… - The American journal of …, 2002 - Elsevier
Patients with severe heart failure have plasma cytokine concentrations that are more than
twofold greater than those in patients with moderate heart failure. Although pentoxifylline, an …

Pentoxifylline in ischemic, hypertensive and idiopathic‐dilated cardiomyopathy: effects on left‐ventricular function, inflammatory cytokines and symptoms

P Bahrmann, UM Hengst, BM Richartz… - European journal of …, 2004 - Wiley Online Library
Introduction: Tumor necrosis factor (TNF)‐α and interleukin‐6 (IL‐6) are significantly
elevated in patients with congestive heart failure (CHF). Pentoxifylline, a xanthin‐derived …

Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy

K Sliwa, D Skudicky, G Candy, T Wisenbaugh, P Sareli - The Lancet, 1998 - thelancet.com
Background There is accumulating evidence that inflammatory cytokines have an important
role in the pathogenesis of heart failure. Plasma concentrations of tumour necrosis factor α …

Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory …

C Kishimoto, K Shioji, M Kinoshita, T Iwase… - International journal of …, 2003 - Elsevier
Although an autoimmune mechanism has been postulated for myocarditis and dilated
cardiomyopathy, immunosuppressive agents had not been shown to be effective. Potential …

Immunomodulatory effect of pentoxifylline in suppressing experimental autoimmune myocarditis

H Takehana, T Inomata, H Niwano, M Nishii… - Circulation …, 2002 - jstage.jst.go.jp
Immunomodulatory Effect of Pentoxifylline in Suppressing Experimental Autoimmune
Myocarditis Page 1 iologically active molecules are important in the pathogenesis of heart …

Effect of thalidomide in patients with chronic heart failure

L Gullestad, AG Semb, E Holt, R Skårdal, T Ueland… - American Heart …, 2002 - Elsevier
Background Congestive heart failure (CHF) is characterized by enhanced immune
activation, which possibly plays a pathogenic role in this disorder. We therefore examined …

Immunological mechanisms of pentoxifylline in chronic heart failure

SM Shaw, MKH Shah, SG Williams… - European journal of …, 2009 - Wiley Online Library
The progressive syndrome of chronic heart failure (CHF) represents a common disease
pathway that may be derived from a host of varying insults (including myocardial ischaemia …

Inflammation, cytokines and anti-inflammatory therapies in heart failure.

JY Tabet, ME Lopes, S Champagne, JB Su… - … des maladies du …, 2002 - europepmc.org
Both experimental and clinical studies have shown a role for inflammation in the
pathogenesis of heart failure. This seems related to an imbalance between pro-inflammatory …

Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure

L Gullestad, H Aass, JG Fjeld, L Wikeby… - Circulation, 2001 - Am Heart Assoc
Background—Congestive heart failure (CHF) is characterized by enhanced immune
activation, and immune-mediated mechanisms may play a pathogenic role in this disorder …